GeneDx, Inc

Sell-side

Financial Advisor, May 2022

Sale of GeneDx, Inc., a Subsidiary of OPKO Health, Inc. (NASDAQ: OPK) to Sema4 Holdings Corp. (SMFR)

OPKO Health is a medical test and medication company focused on diagnostics and pharmaceuticals.

GeneDx, Inc. is a global leader in genomics, providing advanced genomic testing to patients and their families. Originally founded by scientists from the National Institutes of Health, GeneDx offers a world-renowned clinical genomics program with industry-leading expertise in exome sequencing for pediatric rare and ultra-rare genetic disorders. In addition to its market-leading exome sequencing service, GeneDx offers a comprehensive suite of genetic testing services. GeneDx is a subsidiary of BioReference Laboratories, Inc., a wholly owned subsidiary of OPKO Health, Inc.

More Like This

Apr 2022
Proven Behavior Solutions Logo

Strategic Investment From Health Enterprise Partners

Exclusive Financial Advisor

View Details
Feb 2022

Sale to Labcorp (NYSE: LH)

Exclusive Financial Advisor

View Details
Jul 2021

Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, MD acquired by BioNTech

Financial Advisor

View Details